Funding for this research was provided by:
Parker Institute for Cancer Immunotherapy
Article History
Received: 15 May 2020
First Online: 2 June 2020
Disclosures
: Adil Daud - Research Funding from Novartis, Roche/Genentech, Pfizer, BMS, Merck, Checkmate, Incyte and OncoSec. Stock in Trex bio.